Protalix BioTherapeutics ... (PLX)
2.30
-0.03 (-1.29%)
At close: Mar 03, 2025, 3:59 PM
2.30
0.00%
After-hours: Mar 03, 2025, 04:50 PM EST
Protalix BioTherapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Revenue | 65.49M | 47.64M | 38.35M | 62.9M | 54.69M | 34.24M | 19.24M | 9.2M | 4.36M | 15.16M | 11.51M | 34.42M | 8.39M | 6.64M | 388K | n/a | n/a | 150K | n/a | n/a | n/a | n/a | n/a | 1.00 | 3.55M | 8.04M | n/a | n/a |
| Cost of Revenue | 22.98M | 19.59M | 16.35M | 10.87M | 10.89M | 9.3M | 15.23M | 8.4M | 730K | 9.05M | 5.43M | 8.14M | 6.94M | 8.98M | 3.58M | n/a | n/a | 35K | n/a | n/a | n/a | n/a | n/a | n/a | 2.68M | 6.31M | n/a | n/a |
| Gross Profit | 42.51M | 28.05M | 22M | 52.02M | 43.8M | 24.94M | 4.01M | 801K | 3.63M | 6.11M | 6.08M | 26.28M | 1.44M | -2.34M | -3.19M | n/a | n/a | 115K | n/a | n/a | n/a | n/a | n/a | 1.00 | 871.16K | 1.73M | n/a | n/a |
| Operating Income | 10.46M | -13.01M | -20.46M | 1.85M | -10.72M | -19.31M | -36.35M | -33.16M | -23.67M | -25.2M | -27.12M | -12.17M | -36.53M | -29.97M | -31.97M | -24.17M | -24.57M | -9.77M | -93.3K | -165.58K | -147.38K | -165.79K | -385.79K | -381.85K | -816.21K | -1.17M | -164.38K | -44.06K |
| Interest Income | 1.29M | 1.15M | 401K | 438K | 407K | 536K | 188K | 589K | 123K | 196K | n/a | 588K | n/a | n/a | n/a | 1.76M | 2.08M | 344K | 14.15K | 5.51K | 6.67K | 15.72K | 56.62K | 126.01K | n/a | 78.84K | n/a | 243.74K |
| Pretax Income | 8.57M | -14.4M | -27.58M | -6.52M | -18.28M | -26.46M | -85.28M | -29.18M | -27.28M | -29.94M | -27.79M | -11.62M | 2K | 29M | 31.44M | 22.41M | -2.08M | 5.75M | -89.08K | n/a | n/a | -165.48K | -479.79K | -231.62K | -1.07M | n/a | 179.46K | 199.69K |
| Net Income | 8.31M | -14.93M | -33.98M | -14.89M | -26.24M | -26.46M | -85.28M | -29.36M | 58.04M | -29.94M | -27.79M | -11.62M | -36.53M | -29M | -31.44M | -22.41M | -22.48M | -9.39M | -74.93K | -160.07K | -140.71K | -149.76K | -329.17K | -105.61K | -997.87K | -1.15M | 118.44K | 131.68K |
| Selling & General & Admin | 14.96M | 11.71M | 12.73M | 11.15M | 9.9M | 10.92M | 11.53M | 9.36M | 7.28M | 9.66M | 8.38M | 9.76M | 6.93M | 6.88M | 7.14M | 6.77M | 11.71M | 4.53M | 93.3K | 165.58K | 147.38K | 165.79K | 291.79K | 381.85K | 1.52M | 2.09M | 164.38K | 44.06K |
| Research & Development | 17.09M | 29.35M | 29.73M | 38.17M | 44.62M | 33.33M | 28.83M | 24.61M | 20.02M | 21.65M | 24.82M | 28.69M | 31.04M | 29.95M | 21.64M | 17.4M | 12.86M | 5.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94K | n/a | 163.2K | 817.93K | n/a | n/a |
| Operating Expenses | 32.05M | 41.06M | 42.46M | 49.31M | 54.52M | 44.25M | 40.36M | 33.96M | 27.3M | 31.31M | 33.2M | 38.45M | 37.97M | 36.83M | 28.78M | 24.17M | 24.57M | 9.77M | 93.3K | 165.58K | 147.38K | 165.79K | 385.79K | 381.85K | 1.69M | 2.9M | 164.38K | 44.06K |
| Interest Expense | 3.18M | 2.53M | 7.52M | 9.67M | 7.97M | 7.68M | 9.72M | 10.66M | 3.73M | 4.93M | n/a | 554K | 2K | 968K | 529K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.57K | n/a | n/a |
| Selling & Marketing Expenses | n/a | 25.29M | 16.75M | 16.24M | 15.87M | 8.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 55.03M | 60.65M | 58.81M | 60.19M | 65.41M | 53.55M | 55.59M | 42.36M | 28.03M | 40.36M | 38.63M | 46.6M | 44.92M | 45.81M | 32.36M | 24.17M | 24.57M | 9.77M | 93.3K | 165.58K | 147.38K | 165.79K | 385.79K | 381.85K | 4.37M | 9.21M | 164.38K | 44.06K |
| Income Tax | 254K | 530K | 6.4M | 8.37M | 7.97M | 536K | 7.8M | 10.85M | -87.57M | -2.94M | n/a | n/a | 43.31M | 48.79M | 62.88M | 44.83M | -2.09M | 11.15M | -14.15K | 160.07K | 140.71K | -15.72K | -150.62K | -126.01K | 181.65K | -27.27K | 61.02K | 68K |
| Shares Outstanding (Basic) | 67.51M | 48.47M | 44.14M | 29.15M | 14.84M | 14.71M | 13.11M | 101.39M | 94.92M | 92.89M | 92.37M | 90.85M | 84.65M | 80.96M | 76.94M | 75.89M | 6.72M | 29.3M | 18.8M | 18.8M | 291.54K | 291.54K | 322.85K | 401.46K | 521.73K | 456.37K | 254K | 216.47K |
| Shares Outstanding (Diluted) | 82.42M | 48.47M | 44.14M | 29.15M | 14.84M | 14.71M | 13.11M | 101.39M | 94.92M | 92.89M | 92.37M | 90.85M | 84.65M | 80.96M | 76.94M | 75.89M | 6.72M | 29.3M | 18.8M | 18.8M | 291.54K | 291.54K | 322.85K | 401.46K | 521.73K | 456.37K | 254.29K | 216.47K |
| EPS (Basic) | 0.12 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 | -0.3 | -0.13 | -0.43 | -0.36 | -0.41 | -0.3 | -3.35 | -0.32 | -0.00 | -0.01 | -0.48 | -0.51 | -1.02 | -0.26 | -1.91 | -2.51 | 0.47 | 0.61 |
| EPS (Diluted) | 0.10 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 | -0.3 | -0.13 | -0.43 | -0.36 | -0.41 | -0.3 | -3.35 | -0.32 | -0.00 | -0.01 | -0.48 | -0.51 | -1.02 | -0.26 | -1.91 | -2.51 | 0.47 | 0.61 |
| EBITDA | 11.65M | -10.78M | -18.94M | 4.45M | -8.69M | -17.1M | -71.8M | -16.53M | -21.18M | -25.42M | -23.58M | -7.93M | -32.91M | -26.83M | -29.98M | -21.18M | -21.79M | -8.99M | -5.48M | -2.29M | -147.38K | -166.1K | -291.79K | -532.08K | -653.01K | -971.87K | -164.38K | -44.06K |
| Depreciation & Amortization | 1.19M | 1.09M | 1.12M | 1.3M | 1.62M | 1.67M | 1.92M | 1.98M | 2.37M | 3.14M | 3.54M | 3.69M | 3.63M | 3.13M | 1.99M | 1.3M | 759K | 502K | -4.21K | n/a | n/a | -312 | 94K | -150.23K | 163.2K | 202.21K | n/a | n/a |